Evidence map›Paper›PMID 42282577›Full record

ArticlebioRxiv : the preprint server for biology2026

Single-Cell Transcriptomic Mapping of PD-L1/TLR4 Remodeling Informs Topical Immunoprevention Timing in Skin Carcinogenesis.

Ran Wei, Rudramani Pokhrel, Delaney Stratton, Sara Centuori, Clara Curiel-Lewandrowski, Georg T Wondrak, Sally E Dickinson, Bonnie J LaFleur, Xiaoxiao Sun

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ran WeiDepartment of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, The University of Arizona, Tucson, Arizona, USA.ORCID 0009-0006-9196-2927
Rudramani PokhrelThe University of Arizona Cancer Center, The University of Arizona, Tucson, Arizona, USA.ORCID 0000-0002-7208-0420
Delaney StrattonThe University of Arizona Cancer Center, The University of Arizona, Tucson, Arizona, USA.ORCID 0000-0002-3285-345X
Sara CentuoriThe University of Arizona Cancer Center, The University of Arizona, Tucson, Arizona, USA.ORCID 0009-0004-3619-4203
Clara Curiel-LewandrowskiThe University of Arizona Cancer Center, The University of Arizona, Tucson, Arizona, USA.ORCID 0000-0001-8982-6252
Georg T WondrakThe University of Arizona Cancer Center, The University of Arizona, Tucson, Arizona, USA.ORCID 0000-0003-4799-8608
Sally E DickinsonThe University of Arizona Cancer Center, The University of Arizona, Tucson, Arizona, USA.ORCID 0000-0002-2049-543X
Bonnie J LaFleurThe University of Arizona Cancer Center, The University of Arizona, Tucson, Arizona, USA.ORCID 0000-0002-4939-9337
Xiaoxiao SunDepartment of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, The University of Arizona, Tucson, Arizona, USA.ORCID 0000-0003-1438-1951

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
Targeted Prevention for Non-Melanoma Skin CancerP01CA229112 · NCI · UNIVERSITY OF ARIZONA · PI MANSOUR, HEIDI M. · 2019 to 2023
$7.1M
Investigating novel targets for topical immunoprevention of keratinocytic skin cancerUG3CA290443 · NCI · UNIVERSITY OF ARIZONA · PI Clara Curiel-Lewandrowski, Sally E Dickinson · 2025 to 2026
$917k
NCI NIH HHS P01 CA229112NCI NIH HHS P30 CA023074NCI NIH HHS UG3 CA290443
6 · The paper itself

Abstract

Cutaneous squamous cell carcinoma (cSCC) represents a growing public health burden, with incidence projected to increase 23-29% over the coming decade. Topical immunoprevention strategies targeting the PD-L1/PD-1 and TLR4 axes have demonstrated preclinical efficacy, yet optimal intervention timing in humans remains undefined. To address this gap, single-cell RNA sequencing was performed on matched sun-protected (SP), sun-damaged (SD), and actinic keratosis (AK) biopsies from the same individuals, along with independent cSCC cases. Immune checkpoint and innate inflammatory signals were detectable as early as SD skin, prior to histologically confirmed dysplasia. Monotonically increasing expression of CD274 (PD-L1), CTLA4, PDCD1, CD27, and STAT1, alongside progressive TLR4-MYD88 innate immune signaling, was revealed through pseudobulk data analysis, with earliest upregulation at the SD stage. Fuzzy c-means trajectory clustering identified cell-type-specific programs across dendritic cells, macrophages, T cells, fibroblasts, endothelial cells, and keratinocytes. Dendritic cells shifted from early inflammatory antigen-presenting programs toward late PD-L1/IFN-regulatory states; macrophages showed monotonically increasing TLR4-associated myeloid activation; and T cells defined a "hot but exhausted" microenvironment in established cSCC. These findings identify SD and AK as biologically active stages for topical immunoprevention and provide a cellular roadmap for PD-L1/PD-1 and TLR4 blockade strategies.

Indexed as

actinic keratosiscutaneous squamous cell carcinomaPD-L1single-cell RNA sequencingTLR4

Identifiers

PMID42282577
PMCPMC13251948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.